col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Public Library of Science: PLoS Biology
  original article Date Title Authors   All Authors
1 [GO] 2021―Aug―06 Challenges in interpreting cytokine data in COVID-19 affect patient care and management Stephen Y. Wang, Takehiro Takahashi, Alexander B. Pine, William E. Damsky, Michael Simonov, Yanhua Zhang, et al. (+8)
2 [GO] 2021―Jul―12 Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies Stephen M. Kissler, Joseph R. Fauver, Christina Mack, Scott W. Olesen, Caroline Tai, Kristin Y. Shiue, et al. (+13)
3 [GO] 2021―Jun―18 The landscape of antibody binding in SARS-CoV-2 infection Anna S. Heffron, Sean J. McIlwain, Maya F. Amjadi, David A. Baker, Saniya Khullar, Tammy Armbrust, et al. (+8)
4 [GO] 2021―Jun―17 Strategic testing approaches for targeted disease monitoring can be used to inform pandemic decision-making James D. Nichols, Tiffany L. Bogich, Emily Howerton, Ottar N. Bjørnstad, Rebecca K. Borchering, Matthew Ferrari, et al. (+9)
5 [GO] 2021―May―25 A generation of junior faculty is at risk from the impacts of COVID-19 Tiffany Lowe-Power, Louise Dyson, Abigail M. Polter
6 [GO] 2021―May―07 Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2 Chantal B. F. Vogels, Mallery I. Breban, Isabel M. Ott, Tara Alpert, Mary E. Petrone, Anne E. Watkins, et al. (+34)
7 [GO] 2021―May―07 Structural basis for SARS-CoV-2 neutralizing antibodies with novel binding epitopes Dan Fu, Guangshun Zhang, Yuhui Wang, Zheng Zhang, Hengrui Hu, Shu Shen, et al. (+32)
8 [GO] 2021―Apr―29 Validation testing to determine the sensitivity of lateral flow testing for asymptomatic SARS-CoV-2 detection in low prevalence settings: Testing frequency and public health messaging is key Jack Ferguson, Steven Dunn, Angus Best, Jeremy Mirza, Benita Percival, Megan Mayhew, et al. (+12)
9 [GO] 2021―Apr―29 Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies Xing Zhu, Dhiraj Mannar, Shanti S. Srivastava, Alison M. Berezuk, Jean-Philippe Demers, James W. Saville, et al. (+8)
10 [GO] 2021―Apr―26 The first few days of a SARS-CoV-2 infection viewed at single-cell resolution Tom Gallagher, Paul B. McCray
11 [GO] 2021―Apr―21 Evaluation of COVID-19 vaccination strategies with a delayed second dose Seyed M. Moghadas, Thomas N. Vilches, Kevin Zhang, Shokoofeh Nourbakhsh, Pratha Sah, Meagan C. Fitzpatrick, et al. (+2)
12 [GO] 2021―Apr―02 The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape Nicholas Fraser, Liam Brierley, Gautam Dey, Jessica K. Polka, Máté Pálfy, Federico Nanni, et al. (+2)
13 [GO] 2021―Mar―29 Disparate temperature-dependent virus-host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium Philip V’kovski, Mitra Gultom, Jenna N. Kelly, Silvio Steiner, Julie Russeil, Bastien Mangeat, et al. (+17)
14 [GO] 2021―Mar―24 SARS-CoV-2 variants reveal features critical for replication in primary human cells Marie O. Pohl, Idoia Busnadiego, Verena Kufner, Irina Glas, Umut Karakus, Stefan Schmutz, et al. (+7)
15 [GO] 2021―Mar―22 A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2 Kwang Su Kim, Keisuke Ejima, Shoya Iwanami, Yasuhisa Fujita, Hirofumi Ohashi, Yoshiki Koizumi, et al. (+9)
16 [GO] 2021―Mar―17 Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes Neal G. Ravindra, Mia Madel Alfajaro, Victor Gasque, Nicholas C. Huston, Han Wan, Klara Szigeti-Buck, et al. (+22)
17 [GO] 2021―Mar―12 Natural selection in the evolution of SARS-CoV-2 in bats created a generalist virus and highly capable human pathogen Oscar A. MacLean, Spyros Lytras, Steven Weaver, Joshua B. Singer, Maciej F. Boni, Philippe Lemey, et al. (+3)
18 [GO] 2021―Mar―09 Rebuild the Academy: Supporting academic mothers during COVID-19 and beyond Robinson W. Fulweiler, Sarah W. Davies, Jennifer F. Biddle, Amy J. Burgin, Emily H. G. Cooperdock, Torrance C. Hanley, et al. (+7)
19 [GO] 2021―Mar―08 Racism, disease, and vaccine refusal: People of color are dying for access to COVID-19 vaccines Susan M. Reverby
20 [GO] 2021―Feb―25 A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research Suzannah J. Rihn, Andres Merits, Siddharth Bakshi, Matthew L. Turnbull, Arthur Wickenhagen, Akira J. T. Alexander, et al. (+77)
21 [GO] 2021―Feb―17 COVID-19 induces a hyperactive phenotype in circulating platelets Shane P. Comer, Sarah Cullivan, Paulina B. Szklanna, Luisa Weiss, Steven Cullen, Sarah Kelliher, et al. (+15)
22 [GO] 2020―Dec―21 The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins Carina Conceicao, Nazia Thakur, Stacey Human, James T. Kelly, Leanne Logan, Dagmara Bialy, et al. (+18)
23 [GO] 2020―Dec―15 A sensitive and affordable multiplex RT-qPCR assay for SARS-CoV-2 detection Martin A. M. Reijns, Louise Thompson, Juan Carlos Acosta, Holly A. Black, Francisco J. Sanchez-Luque, Austin Diamond, et al. (+33)
24 [GO] 2020―Dec―15 Rapid detection of SARS-CoV-2 with CRISPR-Cas12a Dan Xiong, Wenjun Dai, Jiaojiao Gong, Guande Li, Nansong Liu, Wei Wu, et al. (+12)
25 [GO] 2020―Nov―12 Superspreading events in the transmission dynamics of SARS-CoV-2: Opportunities for interventions and control Benjamin M. Althouse, Edward A. Wenger, Joel C. Miller, Samuel V. Scarpino, Antoine Allard, Laurent Hébert-Dufresne, Hao Hu
26 [GO] 2020―Nov―09 Monitor for COVID-19 vaccine resistance evolution during clinical trials David A. Kennedy, Andrew F. Read
27 [GO] 2020―Nov―06 A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19 Yadi Zhou, Yuan Hou, Jiayu Shen, Reena Mehra, Asha Kallianpur, Daniel A. Culver, et al. (+13)
28 [GO] 2020―Oct―16 The COVID-19 response illustrates that traditional academic reward structures and metrics do not reflect crucial contributions to modern science Adam J. Kucharski, Sebastian Funk, Rosalind M. Eggo
29 [GO] 2020―Oct―07 Detection of SARS-CoV-2 RNA by multiplex RT-qPCR Eriko Kudo, Benjamin Israelow, Chantal B. F. Vogels, Peiwen Lu, Anne L. Wyllie, Maria Tokuyama, et al. (+16)
30 [GO] 2020―Oct―02 Direct RT-qPCR detection of SARS-CoV-2 RNA from patient nasopharyngeal swabs without an RNA extraction step Emily A. Bruce, Meei-Li Huang, Garrett A. Perchetti, Scott Tighe, Pheobe Laaguiby, Jessica J. Hoffman, et al. (+14)
31 [GO] 2020―Sep―08 In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age Nicole A. P. Lieberman, Vikas Peddu, Hong Xie, Lasata Shrestha, Meei-Li Huang, Megan C. Mears, et al. (+10)
32 [GO] 2020―Aug―27 Recommendations for future university pandemic responses: What the first COVID-19 shutdown taught us Carolyn Coyne, Jimmy D. Ballard, Ira J. Blader
33 [GO] 2020―Aug―21 Real-time public health communication of local SARS-CoV-2 genomic epidemiology Chaney C. Kalinich, Cole G. Jensen, Peter Neugebauer, Mary E. Petrone, Mario Peña-Hernández, Isabel M. Ott, et al. (+6)
34 [GO] 2020―Aug―06 Integrative illustration for coronavirus outreach David S. Goodsell, Maria Voigt, Christine Zardecki, Stephen K. Burley
35 [GO] 2020―Jun―08 A unifying structural and functional model of the coronavirus replication organelle: Tracking down RNA synthesis Eric J. Snijder, Ronald W. A. L. Limpens, Adriaan H. de Wilde, Anja W. M. de Jong, Jessika C. Zevenhoven-Dobbe, Helena J. Maier, et al. (+4)
36 [GO] 2020―Apr―24 Leveraging open hardware to alleviate the burden of COVID-19 on global health systems Andre Maia Chagas, Jennifer C. Molloy, Lucia L. Prieto-Godino, Tom Baden

[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.010 sec